DK322188A - Fremgangsmaade til fremstilling af protein - Google Patents

Fremgangsmaade til fremstilling af protein

Info

Publication number
DK322188A
DK322188A DK322188A DK322188A DK322188A DK 322188 A DK322188 A DK 322188A DK 322188 A DK322188 A DK 322188A DK 322188 A DK322188 A DK 322188A DK 322188 A DK322188 A DK 322188A
Authority
DK
Denmark
Prior art keywords
procedure
host cells
producing protein
proteins
source
Prior art date
Application number
DK322188A
Other languages
Danish (da)
English (en)
Other versions
DK322188D0 (da
Inventor
Joseph John Patroni
Malcolm Roy Brandon
Original Assignee
Bunge Australia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bunge Australia filed Critical Bunge Australia
Publication of DK322188D0 publication Critical patent/DK322188D0/da
Publication of DK322188A publication Critical patent/DK322188A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK322188A 1987-06-15 1988-06-14 Fremgangsmaade til fremstilling af protein DK322188A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPI247287 1987-06-15

Publications (2)

Publication Number Publication Date
DK322188D0 DK322188D0 (da) 1988-06-14
DK322188A true DK322188A (da) 1988-12-17

Family

ID=3772234

Family Applications (1)

Application Number Title Priority Date Filing Date
DK322188A DK322188A (da) 1987-06-15 1988-06-14 Fremgangsmaade til fremstilling af protein

Country Status (14)

Country Link
US (1) US4992531A (no)
JP (1) JPS6447389A (no)
KR (1) KR0126767B1 (no)
CN (1) CN1032425C (no)
AT (1) ATE114156T1 (no)
AU (1) AU609824B2 (no)
CA (1) CA1305284C (no)
DE (1) DE3852116T2 (no)
DK (1) DK322188A (no)
ES (1) ES2065911T3 (no)
IE (1) IE66334B1 (no)
NO (1) NO882635L (no)
NZ (1) NZ225032A (no)
ZA (1) ZA884212B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
EP0295859B1 (en) * 1987-06-15 1994-11-17 Southern Cross Biotech Pty.Ltd. Production of proteins in active forms
US5102989A (en) * 1991-03-15 1992-04-07 Merck & Co., Inc. Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
JPH0774232B2 (ja) * 1992-08-31 1995-08-09 農林水産省食品総合研究所長 界面活性剤を用いたタンパク質の新規な精製法
JP3279362B2 (ja) * 1992-10-05 2002-04-30 井上 聰一 糖尿病判定方法及び糖尿病判定装置
JP3319812B2 (ja) * 1993-04-05 2002-09-03 井上 聰一 リウマチ判定方法及びリウマチ判定装置
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
CA2338665C (en) 1998-08-06 2011-01-18 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
IL152804A0 (en) * 2000-05-16 2003-06-24 Bolder Biotechnology Inc Methods for refolding proteins containing free cysteine residues
ATE513838T1 (de) * 2002-09-20 2011-07-15 Promega Corp Auf lumineszenz basierende verfahren und sonden zur messung der cytochrom-p450-aktivität
AU2003298594A1 (en) * 2002-11-01 2004-06-07 Promega Corporation Cell lysis compositions, methods of use, apparatus, and kit
DE10309691B4 (de) 2003-02-28 2018-10-04 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Gewinnung von löslichen Proteinen aus der Biomasse rekombinanter Mikroorganismen
US20040180445A1 (en) * 2003-03-12 2004-09-16 Domanico Michael J. Methods and compositions for purification of nucleic acid from a host cell
EP1871877A2 (en) 2005-04-11 2008-01-02 Savient Pharmaceuticals, Inc. A variant form of urate oxidase and use thereof
ES2856881T3 (es) 2005-04-11 2021-09-28 Horizon Pharma Rheumatology Llc Formas variantes de urato oxidasa y su uso
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
EP1883425A1 (en) * 2005-05-23 2008-02-06 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
EP2277872B1 (en) * 2005-05-31 2016-03-23 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
ES2532804T3 (es) * 2006-04-12 2015-03-31 Crealta Pharmaceuticals Llc Purificación de proteínas con tensioactivo catiónico
US8617531B2 (en) * 2006-12-14 2013-12-31 Bolder Biotechnology, Inc. Methods of making proteins and peptides containing a single free cysteine
EP2323996B1 (en) * 2008-08-18 2014-10-22 Promega Corporation Luminogenic compounds and methods to detect cytochrome p450 3a enzymes
GB0901434D0 (en) 2009-01-29 2009-03-11 Univ Strathclyde Ballast water treatment system
AU2010265964B2 (en) 2009-06-25 2014-09-18 Horizon Therapeutics Usa, Inc. Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
EP4183773A1 (en) 2010-05-21 2023-05-24 Siemens Healthcare Diagnostics Inc. Zwitterionic reagents
CN102965317A (zh) * 2012-11-27 2013-03-13 江南大学 一种产牛磺酸菌株的筛选方法及用该菌株发酵法生产牛磺酸
EP3099683B1 (en) 2014-01-29 2020-08-05 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
US10131898B2 (en) * 2014-07-22 2018-11-20 Bio-Rad Laboratories, Inc. Buffers for use with polymerases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476049A (en) * 1983-09-20 1984-10-09 Hoffmann-La Roche Inc. Method for the extraction of immune interferon
US4677196A (en) * 1985-09-06 1987-06-30 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
AU597924B2 (en) * 1985-12-11 1990-06-14 Natinco Nv Solubilization of protein aggregates
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms

Also Published As

Publication number Publication date
JPS6447389A (en) 1989-02-21
US4992531A (en) 1991-02-12
CN88103725A (zh) 1988-12-28
DK322188D0 (da) 1988-06-14
CN1032425C (zh) 1996-07-31
ATE114156T1 (de) 1994-12-15
ZA884212B (en) 1989-03-29
KR0126767B1 (ko) 1997-12-29
DE3852116T2 (de) 1995-03-30
AU1763288A (en) 1988-12-15
CA1305284C (en) 1992-07-14
NO882635D0 (no) 1988-06-15
ES2065911T3 (es) 1995-03-01
DE3852116D1 (de) 1994-12-22
IE881815L (en) 1988-12-15
IE66334B1 (en) 1995-12-27
NZ225032A (en) 1991-02-26
NO882635L (no) 1988-12-19
AU609824B2 (en) 1991-05-09
KR900000380A (ko) 1990-01-30

Similar Documents

Publication Publication Date Title
DK322188A (da) Fremgangsmaade til fremstilling af protein
MY101204A (en) Solubilization of protein aggregates
DK512686A (da) Thrombinpraeparater, deres fremstilling og anvendelse
SE8903777L (sv) Liposome/doxorubicin, komposition och foerfarande
BR9106205A (pt) Dispositivo para implantacao em hospedeiro,processo de implantacao,dispositivo implantado,e recipiente de imunoisolamento
DE69529219T2 (de) Helicobacter proteine und impstoffe
FI871288A0 (fi) Menetelmä aprotiniinin valmistamiseksi yhdistelmä-DNA-tekniikalla ja menetelmään soveltuva DNA, ilmentämisplasmidi ja isäntäsolu
IT8819077A0 (it) Processo per la preparazione di 1,2 difluoroetano e di 1,1,2trifluoroetano.
DE69101634D1 (de) Rekombinant hergestellte blutfaktoren, verfahren zur exprimierung besagter blutfaktoren sowie in besagtem prozess verwendeter rekombinanter vaccina-virus.
DK7191A (da) Topisk salve
DE3774897D1 (de) Behandelte sojabohnen mit reduziertem phosphor- und kaliumgehalt, verfahren zur zubereitung derselben und damit erhaltene sojabohnen-nahrungsmittel.
ATE146525T1 (de) Wiedergewinnungsverfahren von mikrobiell erzeugtem chymosin
DE69129747D1 (de) In lösung bringen von proteinen in aktiver form
ATE119543T1 (de) Produktion von proteinen in aktiver form.
ES2182440T3 (es) Procedimiento para la obtencion de 3,7-dialquilxantinas a partir de 3-alquilxantinas.
TR200002611T2 (tr) Beta-lipotropin ve kullanımları
MY103305A (en) Productions of proteins in active forms
ES1000319U (es) Modulo para union o conjuncion de retales de tejidos, pieles o similares

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment